Skip to content

C4 Therapeutics, Inc.

CCCC · XNAS

CIK 1662579fmd_1G5CNQH9XQ04400TAMEK746KQMManufacturing · Biological Products, (No Diagnostic Substances)Template: Standard

Coverage: Jan 01, 2019 to Sep 30, 2026, 29 periods

Ratios computed from the standardized statements. Select a value to open its proof.

Loading
FinancialMD terminal